In its largest acquisition to date, medical equipment manufacturer Drive Medical acquired DeVilbiss Healthcare from Vestar Capital Partners in early July.
Sandoz on Tuesday announced the launch of a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) in 1-mg strength. Sandoz expects to have 180-day generic drug marketing exclusivity for the 1-mg strength.
Mediterra nutrition bars feature various fruits, vegetables, seeds and grains, providing options for different snacking occasions throughout the day.
A recent study showed that up to 74% of women experienced improvement in their breast discomfort after supplementing their diets with iodine.
The new SayAhh! Sore Throat Home Exam Aid is designed to aid parents in examining the throat area.
The Council for Responsible Nutrition will host a conversation with key regulators of the dietary supplement industry at annual meeting.
A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers.
As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply.
In a move that will reshape the generic pharmaceuticals landscape, Teva announced Monday that it would be acquiring Allergan Generics for $40.5 billion.
The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.